Cargando…
Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population
INTRODUCTION: No evidence of disease activity with three components (NEDA-3) is achieved if the person with MS (pwMS) has no new MRI lesions, no new relapses and no change in Expanded disability status scale (EDSS) over 1 year. Whether NEDA-3 is a good tool in measuring disease activity is up for di...
Autores principales: | Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brekke, Kamilla, Brunborg, Cathrine, Berg-Hansen, Pål, Celius, Elisabeth Gulowsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702815/ https://www.ncbi.nlm.nih.gov/pubmed/36452173 http://dx.doi.org/10.3389/fneur.2022.1034056 |
Ejemplares similares
-
The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression
por: Simonsen, Cecilia Smith, et al.
Publicado: (2020) -
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry
por: Simonsen, Cecilia Smith, et al.
Publicado: (2021) -
High prevalence of fatigue in contemporary patients with multiple sclerosis
por: Broch, Line, et al.
Publicado: (2021) -
The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis
por: Simonsen, Cecilia Smith, et al.
Publicado: (2020) -
Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
por: Simonsen, Cecilia Smith, et al.
Publicado: (2016)